Rep. John James bought up to $50K of SPCX stock — 30 days before disclosure

As seen on the 24/7 Wall St. homepage on July 12, 2026.

  • SPCX Space Exploration Technologies Corp. (SPCX)Buy$15K – $50K
Disclosed 30 days after the earliest trade

House Rep John James bought up to $50K of Space Exploration Technologies stock in June, a month before disclosure. The Michigan Republican sits on no space or defense committees, raising questions about the timing and rationale behind the concentrated bet.

Continue ReadingShow less

On June 12, 2026, Michigan Republican John James purchased a position in Space Exploration Technologies Corp. (SPCX) valued at up to $50K. The trade was not publicly disclosed until July 12, 2026 — exactly 30 days later, which is the outer edge of the window lawmakers are permitted under the STOCK Act.

What draws scrutiny is the absence of an obvious committee connection. James does not sit on any space- or defense-related committees, which are the assignments that would most naturally put a lawmaker in the path of material, non-public information about a company in this sector. That gap makes the rationale for a concentrated single-stock bet harder to explain on its face.

Disclosure

*$149 for two years (or $1.43 per week) is an introductory promotion for new members only. 62% discount based on the current list price of Stock Advisor of $199/year. Membership will renew at the then-current list price at the end of the membership term. Stock Advisor returns are 930% as compared to the S&P 500 returns of 185% as of April 7, 2026.

The same investor newsletter that told subscribers to buy Amazon in 2002, Netflix in 2004, and Nvidia in 2005 still publishes two new stock picks every month. Over 23 years, Motley Fool's Stock Advisor has more than quadrupled the S&P 500. New members get this month's picks, the Top 10 Rankings, and a 30-day money-back guarantee. Click here to unlock their next top stocks while new members are still being accepted.

The filing covers a single reported transaction with no additional positions noted. Investors and ethics watchdogs alike will be watching whether James files any follow-on activity in the coming disclosure cycles, and whether the position performs in ways that attract further attention from congressional oversight bodies.

Mentioned: SPCX